Drug intelligence / Profile preview

klotho-encoding messenger RNA

Development stage
Preclinical
Lead developer
Turn Biotechnologies
Modality
mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Klotho-encoding messenger RNA is an investigational mRNA-based therapeutic designed to induce the endogenous production of the Klotho protein, a single-pass transmembrane protein primarily expressed in the kidney that functions as a circulating hormone with potent anti-aging, anti-fibrotic, and renoprotective properties. By delivering the mRNA sequence via lipid nanoparticles (LNPs) or other delivery systems, the therapy aims to restore Klotho levels which typically decline in chronic kidney disease (CKD), acute kidney injury (AKI), and with aging. The mechanism involves the translation of the mRNA by host cells into functional Klotho protein, which then enters the circulation to inhibit TGF-beta signaling, suppress oxidative stress, and modulate phosphate metabolism through its role as a co-receptor for fibroblast growth factor 23 (FGF23).

Other names
alpha-klotho mRNAKlotho mRNA
02

Targets

KL (Klotho Protein)

Beyond the preview

Go deeper on klotho-encoding messenger RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on klotho-encoding messenger RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call